Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium nitroprusside for negative symptoms in treatment-resistant schizophrenia
RBR-2zhgjwPhase 3Completed
- Sponsor
- Federal University of São Paulo
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in schizophrenia comparing sodium nitroprusside with Control: placebo (2 arms). Started May 2018; status: completed.
02
Drugs
sodium nitroprusside
03
Conditions
schizophrenia
Beyond the preview
Go deeper on RBR-2zhgjw.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-2zhgjw.